Abstract:Hypoxia in a solid tumor microenvironment (TME) can lead to the overexpression of hypoxia-inducible factor-1α (HIF-1α), which correlates to tumor metastasis. Reactive oxygen species (ROS) induced tumor cell apoptosis is becoming a promising method in tumor treatment. Currently, the ROS generating systems, e.g., photodynamic treatment and sonodynamic treatment, highly depend on oxygen (O2) in the tumor microenvironment (TME). However, the level of O2 in TME is too low to produce enough ROS. Herein, we developed an ultrasmall DSPE-PEG2000 coated barium titanate nanoparticle (P-BTO) for tumor treatment based on ultrasound triggered piezocatalysis and water splitting. Interestingly, irradiated by ultrasound, the surface of ultasmall P-BTO nanoparticles produced imbalance charges, which induced a cascade of redox reaction processes to simultaneously generate ROS and O2, the latter one was hardly generated in large-sized barium titanate nanoparticles. The as-synthesized P-BTO reached the highest accumulation in the tumor site at 4 h after intravenous injection. The results showed that the produced O2 significantly alleviated the hypoxia of TME to down-regulate the expression of HIF-1α, and the produced ROS can efficiently kill tumor cells. Moreover, the tumor metastasis was also inhibited, providing a different way to treat triple-negative breast cancer, which was easily metastatic and lacked effective treatments in the clinic.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c00616?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c00616</a>.Additional TEM figures for further characterization of 200 nm BTO, BTO nanowires, EDS spectrum of P-BTO, and XPS spectrum of Ba 3d, C 1s, O 1s, and Ti 2p (Supplementary Figure S1); the solution appearance under different conditions (Supplementary Figure S2); fluorescence images of [Ru(dpp)3]Cl2 in 4T1 cells after different treatments with (a) control, (b) US + 200 nm BTO, and (c) US + BTO nanowire (Supplementary Figure S3); cytotoxicity profiles of control group, P-BTO group, US group, and US+P-BTO group under normoxic conditions (Supplementary Figure S4); hemolysis rate of RBCs incubated with P-BTO and complete blood count of health female Balb/c mice at different time points post injection of P-BTO (Supplementary Figure S5); biodistribution of Ba in organs and tumor at 4 h after intravenous injection of P-BTO (Supplementary Figure S6); tumor weight of female Balb/c mice after US+P-BTO treatment (Supplementary Figures S7); histological analysis of major organs by H&E staining after different treatments (Supplementary Figure S8); comparison of the P-BTO with existing procedures (Supplementary Table S1); acronyms and corresponding full names (Supplementary Table S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c00616/suppl_file/nn1c00616_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Plasmon-pyroelectric nanostructures used to produce a temperature-mediated reactive oxygen species for hypoxic tumor therapy

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

Spatiotemporally Synchronous Oxygen Self-Supply and Reactive Oxygen Species Production on Z-Scheme Heterostructures for Hypoxic Tumor Therapy

NIR-absorbing Superoxide Radical and Hyperthermia Photogenerator Via Twisted Donor-Acceptor-donor Molecular Rotation for Hypoxic Tumor Eradication

Thylakoid Membranes with Unique Photosystems Used to Simultaneously Produce Self‐Supplying Oxygen and Singlet Oxygen for Hypoxic Tumor Therapy

Highly Effective Pyroelectric Catalysis for Simultaneous Tumor‐Targeted Dynamic Therapy and Gentle Photothermal Therapy by Oxygen‐Vacancy‐Rich CeO2‐BaTiO3 Nanorods

NIR‐II driven plasmon‐enhanced catalysis for a timely supply of oxygen to overcome hypoxia‐induced radiotherapy tolerance

A Porous Au@Rh Bimetallic Core-Shell Nanostructure as an H<sub>2</sub>O<sub>2</sub>-Driven Oxygenerator to Alleviate Tumor Hypoxia for Simultaneous Bimodal Imaging and Enhanced Photodynamic Therapy

Nanoheterojunction Engineering Enables NIR‐II‐Triggered Photonic Hyperthermia and Pyroelectric Catalysis for Tumor‐Synergistic Therapy

A near-infrared light-controlled, oxygen-independent radical generating nano-system toward cancer therapy

An NIR-II Photothermally Triggered "Oxygen Bomb" for Hypoxic Tumor Programmed Cascade Therapy

Oxygen Self‐Supplying Enzymatic Nanoplatform for Precise and Enhanced Photodynamic Therapy

Spatiotemporally Controlled O2 and Singlet Oxygen Self-Sufficient Nanophotosensitizers Enable the in Vivo High-Yield Synthesis of Drugs and Efficient Hypoxic Tumor Therapy

Trojan horses in tumor: engineered pyroelectric and photodynamic nanocomposites for NIR-induced cell apoptosis and tumor growth inhibition

Oxygen-Evolving Mesoporous Organosilica Coated Prussian Blue Nanoplatform for Highly Efficient Photodynamic Therapy of Tumors.

Tumor microenvironment/NIR-responsive oxygen-irrelevant radical nanogenerator for hypoxia-independent photothermal-thermodynamic osteosarcoma nanotherapy

Redox-activatable photothermal therapy and enzyme-mediated tumor starvation for synergistic cancer therapy

Active-oxygenating hollow Prussian blue nanosystems loaded with biomacromolecules for photodynamic/photothermal therapy of cancer and alleviating hypoxic tumors

Ultrasmall Barium Titanate Nanoparticles for Highly Efficient Hypoxic Tumor Therapy via Ultrasound Triggered Piezocatalysis and Water Splitting

A Hybrid Nanomaterial with NIR-induced Heat and Associated Hydroxyl Radical Generation for Synergistic Tumor Therapy